CARDIOPROGRESS
Foundation for the advancement of cardiology

Why Don't More Women Participate in Cardiac Rehabilitation? The biggest barrier to enrollment and participation in cardiac rehabilitation (CR) among women globally is lack of awareness, an international cross-sectional study suggests.

Cardiac Troponin Predicts Mortality Post Surgery Perioperative myocardial injury, reflected by release of high-sensitivity cardiac troponin T, is associated with 30-day mortality after various cardiac surgeries at postoperative prognostic cutoffs higher than proposed in current definitions, new research suggests.

New Insight Into Genetic Link Between Schizophrenia and CVD There is an extensive genetic overlap between schizophrenia and smoking, but there are also schizophrenia genes that may protect against obesity, illustrating the bidirectional effects of shared loci across cardiovascular disease (CVD) risk factors, results of new research suggest.

Obesity-Related Cardiovascular Disease Deaths Surging In contrast to an overall decline in cardiovascular mortality, obesity-related cardiovascular deaths have risen substantially in the past two decades, most prominently among Black women.

Minimizing Atrial Pacing No Benefit in Sinus Node Disease: DANPACE II Minimizing atrial pacing does not alter the risk of atrial fibrillation (AF) associated with sinus node dysfunction (SND), suggest results of a trial that randomly assigned patients with SND who had received their first pacemaker implant to one of two pacing programs.

Heartbeat: improving outcomes after out-of-hospital cardiac arrest Immediate cardiopulmonary resuscitation (CPR) and early defibrillation are essential in ensuring survival after an out-of-hospital cardiac arrest (OHCA), which is estimated to account for 15–20% of global mortality. Yet widespread training in CPR and availability of public defibrillators remains suboptimal in many places.

Reproductive Technologies Not Tied to Maternal CVD After a median follow-up of 11 years, women who gave birth with the assistance of reproductive technology were not at increased risk of cardiovascular disease (CVD) compared to those who did not receive this intervention, a new study shows.

Adverse Fetal Environment Is a Cardiovascular Risk Factor Fetal exposure to poorly controlled diabetes or other situations that overtax the heart, or to intrauterine growth restriction, is associated with increased cardiovascular risk, according to the most recent evidence.

Pulmonary hypertension in significant aortic valve disease: a dive into real-world data Left heart disease is the most common cause of pulmonary hypertension (PHT) accounting for over 65% of all diagnosed cases. In over half of these patients, PHT is the consequence of valve dysfunction, predominantly mitral regurgitation. However, echocardiographic evidence of PHT is not infrequent in the setting of aortic valve disease, particularly in patients with severe aortic stenosis (AS) in whom an estimated systolic pulmonary arterial pressure (eSPAP) >60 mm Hg has previously been reported in up to 34%.

Heartbeat: elevated pulmonary pressures in adults with aortic valve disease Left heart disease is the most common cause of pulmonary hypertension (PHT) accounting for over 65% of all diagnosed cases. In over half of these patients, PHT is the consequence of valve dysfunction, predominantly mitral regurgitation. However, echocardiographic evidence of PHT is not infrequent in the setting of aortic valve disease, particularly in patients with severe aortic stenosis (AS) in whom an estimated systolic pulmonary arterial pressure (eSPAP) >60 mm Hg has previously been reported in up to 34%.

AHA Flags Barriers to Women in Interventional Specialties A new scientific statement from the American Heart Association (AHA) addresses barriers to entry and retention of women in interventional vascular fields, including interventional cardiology, interventional radiology, and vascular surgery, and proposes potential solutions.

New Marker of Cardiovascular Risk Discovered in T2D A significant quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes.

Main results of the 2023 European Society of Cardiology Congress The next annual Congress of the European Society of Cardiology was held in a hybrid format (onsite and online) from August 25 to 28, 2023 inAmsterdam (Netherlands). About 31,000 specialists from 150 countries took part in the event. Traditionally, the most anticipated events at the congress are the scientific HOT LINE sessions, where the results of the most important clinical trials are presented for the first time.clinical trials. This year, participants had the opportunity to learn about 29 specially selected randomised trials in 9 sessions over 4 days.

ESC Issues First Comprehensive Cardiomyopathy Guidelines The European Society of Cardiology has released new guidelines for cardiomyopathies, their first major comprehensive international guidelines to address diagnosis and treatment of the broad causes of heart muscle dysfunction.

AHA/ACC Issue Updated Chronic Coronary Disease Guidelines The latest clinical practice guideline for managing patients with chronic coronary disease (CCD) takes an evidence-based and patient-centered approach to care and includes key updates on revascularization, beta-blocker use, and routine functional and anatomic testing. Developed by the American Heart Association (AHA), the American College of Cardiology (ACC), and other specialty societies, the 2023 guideline both updates and consolidates ACC/AHA guidelines previously published in 2012 and 2014 for the management of patients with stable ischemic heart disease.

New AHA/ACC Performance, Quality Metrics for Coronary Revascularization The American Heart Association (AHA) and American College of Cardiology (ACC), in collaboration with several other professional organizations, have published the first comprehensive set of performance and quality measures specific for coronary artery revascularization.

US News Ranks Top Cardiology, Heart Surgery Hospitals Cleveland Clinic in Ohio is once again the number-one hospital for cardiology and heart surgery, according to US News & World Report latest rankings. In the magazine's 2023-2024 list, Cedars-Sinai Medical Center, Los Angeles, California, takes over the number-two spot from Mayo Clinic, Rochester, Minnesota, which drops to No. 3. Cedars-Sinai held the number-three spot on last year's rankings.

Career paths for cardiologists in industry: pharmaceutical, medical insurance, health technology and management consulting Cardiologists have opportunities to transition to different roles outside of traditional clinical care. In this article, we describe the potential opportunities for cardiologists in pharmaceutical, medical insurance, health technology and management consulting. We highlight some unique considerations for each industry and discuss a strategic approach to engage in these opportunities.

New AHA Statement on Ischemia After Cardiac Surgery The American Heart Association (AHA) outlines "considerations" on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.

New ESH Hypertension Guidelines Aim for Simplified Message The European Society of Hypertension (ESH) has released updated and expanded guidelines for the management of hypertension.